UBS/CALL/CSPC PHARMACEUTICAL GROUP/7.71/0.2/14.11.24 | Market Closed - Hong Kong S.E. 04:00:00 2024-05-21 EDT | ||
| 0.074 HKD | -16.85% |
|
| Current month | -9.76% | ||
| 1 month | +72.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about CSPC PHARMACEUTICAL GROUP LTD.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-21 | 0.074 | -16.85% |
| 24-05-20 | 0.089 | +11.25% |
| 24-05-17 | 0.08 | -3.61% |
| 24-05-16 | 0.083 | -5.68% |
| 24-05-14 | 0.088 | -10.20% |
Delayed Quote Hong Kong S.E.
Last update May 21, 2024 at 04:00 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | CSPC PHARMACEUTICAL GROUP LTD. |
| Issuer | UBS |
| 19035 | |
| ISIN | CH1288249621 |
| Date issued | 2023-08-07 |
| Strike | 7.71 $ |
| Maturity | 2024-11-14 (177 Days) |
| Parity | 5 : 1 |
| Emission price | 0.15 $ |
| Emission volume | N/A |
| Settlement | cash |
| Currency | HKD |
Technical Indicators
| Highest since issue | 0.25 $ |
|---|---|
| Lowest since issue | 0.039 $ |
| Spread | 0.002 $ |
| Spread % | 2.63% |
Company Profile
CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows:
- drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%);
- vitamin C (10.1%);
- antibiotics (6.2%);
- other (5%): including anhydrous and raw caffeine.
Net sales are distributed geographically as follows: China (82.8%), Asia (7.2%), Europe (4.6%), the Americas (4.4%) and others (1%).
Sector
-
Ratings for CSPC Pharmaceutical Group Ltd.
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: CSPC Pharmaceutical Group Ltd.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
6.57
HKD
Average target price
9.382
HKD
Spread / Average Target
+42.80%
- Stock Market
- Warrants
- 19035 Warrant